In the largest healthcare buyout announced in the US so far this year, Pamplona Capital Management has agreed to acquire Massachusetts-based Parexel in a cash transaction valued at about $5 billion. Pamplona will pay $88.10 per share, representing a 27.9% premium to Parexel’s stock price the day before reports of a possible sale emerged.